Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
THERAPEUTICSMD, INC.
Jurisdiction of Incorporation/Organization
NEVADA
Year of Incorporation/Organization
Over Five Years Ago
Previous Name(s)
- AMHN, INC.
- CROFF ENTERPRISES INC
- CROFF OIL CO
Item 2 Issuer Principal Place of Business and Contact Information
951 YAMATO ROAD
SUITE 220
BOCA RATON, FL 33431
Phone Number:
subscription required
Item 3. Related Persons
Name
ROBERT G. FINIZIO
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
JAMES C. D'ARECCA
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JOHN C.K. MILLIGAN, IV
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
KAREN L. LING
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MICHAEL DONEGAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
EDWARD BORKOWSKI
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MARLAN D. WALKER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
TOMMY G. THOMPSON
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ANGUS C. RUSSELL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
J. MARTIN CARROLL
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GAIL K. NAUGHTON
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
PAUL M. BISARO
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
COOPER C. COLLINS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JULES A. MUSING
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
08/05/2020
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
7500000
Total Amount Sold
7500000
Total Remaining to be Sold
0
Clarification of Response
REPRESENTS THE APPROXIMATE VALUE OF THE WARRANTS TO PURCHASE COMMON STOCK ISSUED.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
3
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
THERAPEUTICSMD, INC.
Issuer Signature
/S/ JAMES C. D'ARECCA
Signer Name
JAMES C. D'ARECCA
Signer Title
CHIEF FINANCIAL OFFICER
Signature Date
08/14/2020